MX9300998A - Sistema mejorado de liberacion farmaceutica y metodo para su preparacion. - Google Patents

Sistema mejorado de liberacion farmaceutica y metodo para su preparacion.

Info

Publication number
MX9300998A
MX9300998A MX9300998A MX9300998A MX9300998A MX 9300998 A MX9300998 A MX 9300998A MX 9300998 A MX9300998 A MX 9300998A MX 9300998 A MX9300998 A MX 9300998A MX 9300998 A MX9300998 A MX 9300998A
Authority
MX
Mexico
Prior art keywords
preparation
improved pharmaceutical
release
liberation system
coated
Prior art date
Application number
MX9300998A
Other languages
English (en)
Spanish (es)
Inventor
Nitin Vadilal Sheth
Joseph James Valorose Jr
Keith Anthony Ellway
Madurai Gurusamy Ganesan
Keiran George Mooney
Jerry Bain Johnson
Original Assignee
American Cyanamid Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by American Cyanamid Co filed Critical American Cyanamid Co
Publication of MX9300998A publication Critical patent/MX9300998A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/65—Tetracyclines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A61K9/5084—Mixtures of one or more drugs in different galenical forms, at least one of which being granules, microcapsules or (coated) microparticles according to A61K9/16 or A61K9/50, e.g. for obtaining a specific release pattern or for combining different drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Communicable Diseases (AREA)
  • Organic Chemistry (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Electrotherapy Devices (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Magnetic Treatment Devices (AREA)
  • Laser Surgery Devices (AREA)
  • Magnetic Resonance Imaging Apparatus (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Physical Deposition Of Substances That Are Components Of Semiconductor Devices (AREA)
  • Management, Administration, Business Operations System, And Electronic Commerce (AREA)
  • Position Fixing By Use Of Radio Waves (AREA)
MX9300998A 1992-03-02 1993-02-24 Sistema mejorado de liberacion farmaceutica y metodo para su preparacion. MX9300998A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US07/844,109 US5262173A (en) 1992-03-02 1992-03-02 Pulsatile once-a-day delivery systems for minocycline

Publications (1)

Publication Number Publication Date
MX9300998A true MX9300998A (es) 1993-09-01

Family

ID=25291839

Family Applications (1)

Application Number Title Priority Date Filing Date
MX9300998A MX9300998A (es) 1992-03-02 1993-02-24 Sistema mejorado de liberacion farmaceutica y metodo para su preparacion.

Country Status (24)

Country Link
US (2) US5262173A (OSRAM)
EP (1) EP0558913B1 (OSRAM)
JP (1) JPH069407A (OSRAM)
KR (1) KR100270491B1 (OSRAM)
CN (1) CN1039194C (OSRAM)
AT (1) ATE181504T1 (OSRAM)
AU (1) AU656841B2 (OSRAM)
CA (1) CA2090561C (OSRAM)
CZ (1) CZ283684B6 (OSRAM)
DE (1) DE69325402T2 (OSRAM)
DK (1) DK0558913T3 (OSRAM)
ES (1) ES2134221T3 (OSRAM)
FI (1) FI110163B (OSRAM)
GR (1) GR3031028T3 (OSRAM)
HU (1) HU219580B (OSRAM)
IL (1) IL104865A (OSRAM)
LV (1) LV12399B (OSRAM)
MX (1) MX9300998A (OSRAM)
NO (1) NO307170B1 (OSRAM)
NZ (1) NZ245951A (OSRAM)
PL (1) PL171609B1 (OSRAM)
SG (1) SG47785A1 (OSRAM)
TW (1) TW299235B (OSRAM)
ZA (1) ZA931444B (OSRAM)

Families Citing this family (56)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4031881C2 (de) * 1990-10-08 1994-02-24 Sanol Arznei Schwarz Gmbh Lösungsmittelfreie, oral zu verabreichende pharmazeutische Zubereitung mit verzögerter Wirkstoffreisetzung und Verfahren zu deren Herstellung
WO1996010996A1 (en) * 1993-07-21 1996-04-18 The University Of Kentucky Research Foundation A multicompartment hard capsule with control release properties
US5538737A (en) * 1994-11-30 1996-07-23 Applied Analytical Industries, Inc. Oral compositions of H2 -antagonists
GB9518465D0 (en) * 1995-09-09 1995-11-08 Smithkline Beecham Seiyaku Kk Pharmaceuticals
ZA974359B (en) * 1996-05-23 1998-05-12 Zeneca Ltd Microencapsulated compositions.
US5932437A (en) * 1998-04-13 1999-08-03 Genesis Laboratories, Inc. Control of lyme disease spirochete
CN1406126A (zh) * 1998-10-01 2003-03-26 诺瓦提斯公司 新型缓释口服制剂
JP2000119181A (ja) 1998-10-06 2000-04-25 Kureha Chem Ind Co Ltd エスクレチン及びその誘導体の放出制御経口製剤
US20060240105A1 (en) * 1998-11-02 2006-10-26 Elan Corporation, Plc Multiparticulate modified release composition
US20090149479A1 (en) * 1998-11-02 2009-06-11 Elan Pharma International Limited Dosing regimen
CA2348871C (en) * 1998-11-02 2009-04-14 John G. Devane Multiparticulate modified release composition
US6432448B1 (en) 1999-02-08 2002-08-13 Fmc Corporation Edible coating composition
US6723342B1 (en) 1999-02-08 2004-04-20 Fmc Corporation Edible coating composition
US20050137181A1 (en) * 1999-03-17 2005-06-23 Bonner Ernest L. Method for treatment of reactive arthritis or bursitis
US7691831B2 (en) * 1999-03-17 2010-04-06 Ernest L. Bonner, Jr. Pharmaceutical combination and method for treatment of reactive arthritis or bursitis
US7884090B2 (en) * 1999-03-17 2011-02-08 Ernest L. Bonner, Jr. Compositions and methods for the treatment of arthritis
US6765000B2 (en) * 1999-03-17 2004-07-20 Bonner Jr Ernest L Treatment for reactive arthritis or bursitis
US20030170181A1 (en) * 1999-04-06 2003-09-11 Midha Kamal K. Method for preventing abuse of methylphenidate
JP2002541092A (ja) 1999-04-06 2002-12-03 ファーマクエスト・リミテッド メチルフェニデートのパルス性送達のための薬学的投薬形態
US6500462B1 (en) 1999-10-29 2002-12-31 Fmc Corporation Edible MCC/PGA coating composition
US10179130B2 (en) 1999-10-29 2019-01-15 Purdue Pharma L.P. Controlled release hydrocodone formulations
ATE526950T1 (de) 1999-10-29 2011-10-15 Euro Celtique Sa Hydrocodon-formulierungen mit gesteuerter freisetzung
IL149282A (en) * 1999-10-29 2010-05-31 Fmc Corp Edible coating composition
EP2283829A1 (en) 2000-10-30 2011-02-16 Euro-Celtique S.A. Controlled release hydrocodone formulations
US6932861B2 (en) 2000-11-28 2005-08-23 Fmc Corporation Edible PGA coating composition
EP1339395A2 (en) 2000-11-28 2003-09-03 Fmc Corporation Edible pga (propylene glycol alginate) coating composition
AU2002256092C1 (en) * 2001-04-05 2009-10-15 Collagenex Pharmaceuticals, Inc. Controlled delivery of tetracycline compounds and tetracycline derivatives
WO2002100381A1 (en) * 2001-06-07 2002-12-19 Tanabe Seiyaku Co., Ltd. Functional grain-containing preparations quickly disintegrated in the oral cavity
US6958161B2 (en) 2002-04-12 2005-10-25 F H Faulding & Co Limited Modified release coated drug preparation
NZ536273A (en) 2002-12-20 2007-08-31 Hoffmann La Roche High dose ibandronate formulation
CA2894736C (en) 2003-04-07 2019-07-16 Supernus Pharmaceuticals, Inc. Once daily formulations of tetracyclines
GB2414668B (en) * 2004-06-03 2009-07-29 Dexcel Ltd Tetracycline modified release delivery system
EP1768668A2 (en) 2004-06-16 2007-04-04 Tap Pharmaceutical Products, Inc. Multiple ppi dosage form
US20060121112A1 (en) * 2004-12-08 2006-06-08 Elan Corporation, Plc Topiramate pharmaceutical composition
JP2008535922A (ja) * 2005-04-12 2008-09-04 エラン・ファルマ・インターナショナル・リミテッド 細菌感染を治療するためのセファロスポリンを含む放出制御組成物
US20080241235A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US20080242642A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US8252776B2 (en) 2007-04-02 2012-08-28 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US7544373B2 (en) * 2007-04-02 2009-06-09 Medicis Pharmaceutical Corporation Minocycline oral dosage forms for the treatment of acne
US9192615B2 (en) 2008-08-06 2015-11-24 Medicis Pharmaceutical Corporation Method for the treatment of acne and certain dosage forms thereof
US8722650B1 (en) 2005-06-24 2014-05-13 Medicis Pharmaceutical Corporation Extended-release minocycline dosage forms
US7919483B2 (en) * 2005-06-24 2011-04-05 Medicis Pharmaceutical Corporation Method for the treatment of acne
US7541347B2 (en) * 2007-04-02 2009-06-02 Medicis Pharmaceutical Coropration Minocycline oral dosage forms for the treatment of acne
WO2007038867A1 (en) * 2005-10-04 2007-04-12 Mistral Pharma Inc. Controlled-release oral dosage form
US20070166273A1 (en) * 2006-01-19 2007-07-19 Krivulka Joseph J Skin treatment educational kit
PT103661B (pt) * 2007-02-23 2010-09-07 Hovione Farmaciencia S A Processo de preparação de minociclina base cristalina
EP2137182A1 (en) * 2007-03-16 2009-12-30 Elan Pharma International Limited Combination of a narcotic and a non-narcotic analgesic
US20080241197A1 (en) * 2007-04-02 2008-10-02 Medicis Pharmaceutical Corporation Minocycline dosage forms for the treatment of acne
CN102014638A (zh) 2007-10-12 2011-04-13 武田制药北美公司 与食物摄入无关的治疗胃肠病症的方法
WO2012145749A1 (en) 2011-04-22 2012-10-26 Napo Pharmaceuticals, Inc. Pharmacologically optimized multimodal drug delivery system for nordihydroguiaretic acid (ndga)
ES2755075T3 (es) 2011-05-05 2020-04-21 Hennig Arzneimittel Gmbh&Co Kg Forma farmacológica para la liberación dirigida de principios activos
DE102011075354A1 (de) * 2011-05-05 2012-11-08 Hennig Arzneimittel Gmbh & Co. Kg Arzneiform zur gezielten Freigabe von Wirkstoffen
US9561241B1 (en) 2011-06-28 2017-02-07 Medicis Pharmaceutical Corporation Gastroretentive dosage forms for minocycline
WO2016162754A1 (en) 2015-04-07 2016-10-13 Dr. Reddy's Laboratories Ltd. Pharmaceutical compositions for minocycline
CN108414466A (zh) * 2018-03-09 2018-08-17 浙江美华鼎昌医药科技有限公司 一种盐酸米诺环素缓释片体外溶出测定方法
EP3810114A4 (en) * 2018-04-30 2022-01-19 Melinta Therapeutics, Inc. METHODS OF TREATING BACTERIAL INFECTIONS USING ORITAVANCIN

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL122039C (OSRAM) * 1960-10-20
US3865935A (en) * 1972-08-10 1975-02-11 Abbott Lab Tableting of erythromycin base
US4250166A (en) * 1977-05-27 1981-02-10 Shionogi & Co., Ltd. Long acting preparation of cefalexin for effective treatments of bacterial infection sensitive to cefalexin
GB1561204A (en) * 1977-06-01 1980-02-13 Ici Ltd Sustained release pharmaceutical composition
US4173626A (en) * 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
FR2447192A1 (fr) * 1979-01-25 1980-08-22 Adria Lab Inc Forme galenique a liberation prolongee d'indoprofene
US4353887A (en) * 1979-08-16 1982-10-12 Ciba-Geigy Corporation Divisible tablet having controlled and delayed release of the active substance
DK150008C (da) * 1981-11-20 1987-05-25 Benzon As Alfred Fremgangsmaade til fremstilling af et farmaceutisk oralt polydepotpraeparat
JPS61210025A (ja) * 1985-03-14 1986-09-18 Teisan Seiyaku Kk 安定化された抗生物質複合顆粒製剤
GB8521494D0 (en) * 1985-08-29 1985-10-02 Zyma Sa Controlled release tablet
US4808413A (en) * 1987-04-28 1989-02-28 E. R. Squibb & Sons, Inc. Pharmaceutical compositions in the form of beadlets and method
US4837030A (en) * 1987-10-06 1989-06-06 American Cyanamid Company Novel controlled release formulations of tetracycline compounds
EP0327295A3 (en) * 1988-02-01 1989-09-06 F.H. FAULDING & CO. LTD. Tetracycline dosage form
US5133974A (en) * 1989-05-05 1992-07-28 Kv Pharmaceutical Company Extended release pharmaceutical formulations
ATE114472T1 (de) * 1989-09-21 1994-12-15 American Cyanamid Co System des typs ''einmal täglich'' zur gepulsten minocyclinabgabe.
EP0418596A3 (en) * 1989-09-21 1991-10-23 American Cyanamid Company Controlled release pharmaceutical compositions from spherical granules in tabletted oral dosage unit form
IT1241417B (it) * 1990-03-06 1994-01-14 Vectorpharma Int Composizioni terapeutiche a rilascio controllato di farmaci supportatisu polimeri reticolati e rivestiti con film polimerici,e loro processodi preparazione
US5286497A (en) * 1991-05-20 1994-02-15 Carderm Capital L.P. Diltiazem formulation

Also Published As

Publication number Publication date
DE69325402D1 (de) 1999-07-29
GR3031028T3 (en) 1999-12-31
IL104865A0 (en) 1993-06-10
CA2090561A1 (en) 1993-09-03
FI930906A0 (fi) 1993-03-01
PL297903A1 (en) 1993-11-15
NO930743L (no) 1993-09-03
US5262173A (en) 1993-11-16
EP0558913A1 (en) 1993-09-08
CZ30093A3 (en) 1994-02-16
FI930906L (fi) 1993-09-03
CN1078889A (zh) 1993-12-01
ATE181504T1 (de) 1999-07-15
IL104865A (en) 1997-02-18
CZ283684B6 (cs) 1998-06-17
TW299235B (OSRAM) 1997-03-01
SG47785A1 (en) 1998-04-17
AU3384293A (en) 1993-09-09
NZ245951A (en) 1994-06-27
NO307170B1 (no) 2000-02-21
PL171609B1 (pl) 1997-05-30
ZA931444B (en) 1993-10-14
LV12399A (lv) 1999-12-20
CN1039194C (zh) 1998-07-22
DK0558913T3 (da) 1999-12-13
ES2134221T3 (es) 1999-10-01
HU219580B (hu) 2001-05-28
LV12399B (en) 2000-06-20
US5348748A (en) 1994-09-20
KR930019209A (ko) 1993-10-18
CA2090561C (en) 2004-10-05
FI110163B (fi) 2002-12-13
NO930743D0 (no) 1993-03-01
DE69325402T2 (de) 2000-02-17
KR100270491B1 (ko) 2000-11-01
HK1009930A1 (en) 1999-06-11
HU9300570D0 (en) 1993-05-28
HUT64851A (en) 1994-03-28
AU656841B2 (en) 1995-02-16
JPH069407A (ja) 1994-01-18
EP0558913B1 (en) 1999-06-23

Similar Documents

Publication Publication Date Title
ES2138584T3 (es) Sistema de suministro de farmacos que implica la reaccion entre una proteina o un polipeptido y un polimero biodegradable hidrofobo.
ES2113095T3 (es) Preparacion solida de liberacion rapida, su produccion y su uso.
PT98442A (pt) Processo para a preparacao do sistema polimerico de administracao de um medicamento
MX9306443A (es) Metodo de triturar sustancias farmaceuticas.
MX9201747A (es) Particulas de resina absorbente entrelazadas en la superficie y revestidas con agente tensioactivo, y metodo para su preparacion
DE68913979D1 (de) Kationenaustauscherharze und carboxylgruppenhaltige Kunstharze enthaltende Arzneizubereitungen mit verzögerter Wirkstofffreisetzung.
ATE53490T1 (de) Arzneipraeparate mit geregelter wirkstoffabgabe.
MX9203716A (es) Agentes de contraste para ultrasonido.
ES2000071A4 (es) Un sistema mascable para el suministro de componentes activos
ES2018468B3 (es) Sistema para la liberacion de sustancias activas a velocidad controlada.
ATE64849T1 (de) Formulierung mit langsamer freisetzung.
AR018252A1 (es) Forma de dosificacion farmaceutica en particulas solidas adecuada para suministro oral.
ES2050070B1 (es) Procedimiento para la preparacion de una composicion destinada a la liberacion prolongada y controlada de una substancia peptidica.
ATE333867T1 (de) Emulgierte arzneistoffabgabesysteme
ITMI922617A1 (it) Forme matriciali multistrato per il rilascio controllato di principi attivi
IL104283A0 (en) Antiviral topical pharmaceutical compositions
DE69325402D1 (de) Verbessertes System des Typs einmal täglich zur gepulsten Minocyclinabgabe
EP0189861A3 (en) Percutaneous absorption accelerator for ionic water-soluble medicine
ES499405A0 (es) Procedimiento para la preparacion de particulas de polifosfatos amonicos para impedir la combustibilidad de sustancias combustibles.
DE69326350D1 (de) Pharmazeutische formulierung
CY1105771T1 (el) Φαρμακευτικες συνθεσεις εφαρμογης στον βλεννογονο
GR3030084T3 (en) Sprayable film forming system releasing active substances for use on plants
BR9508440A (pt) Gel capaz de ser disperso em água sistema de conteinerização compreendendo o mesmo e processo para preparar o gel
BR9202203A (pt) Composicao refrescante para o ar,e,sistema refrescante
BR9814751A (pt) Composição sólida seca para liberação de droga, processo para a preparação da mesma, e, uso de um grande número de partìculas porosas inorgânicas que são compostas de hidroxiapatita de cerâmica.